Zobrazeno 1 - 10
of 358
pro vyhledávání: '"Thomas R, Porter"'
Publikováno v:
Cardiovascular Ultrasound, Vol 22, Iss 1, Pp 1-6 (2024)
Abstract From its inception as a two-dimensional snapshot of the beating heart, echocardiography has become an indelible part of cardiovascular diagnostics. The integration of ultrasound enhancing agents (UEAs) marks a pivotal transition, enhancing i
Externí odkaz:
https://doaj.org/article/93b38045ad6e4759b1f6e0a22fdec35e
Autor:
Thomas R. Porter, Steven B. Feinstein, Roxy Senior, Sharon L. Mulvagh, Petros Nihoyannopoulos, Jordan B. Strom, Wilson Mathias, Beverly Gorman, Arnaldo Rabischoffsky, Michael L. Main, Andrew Appis
Publikováno v:
Echo Research and Practice, Vol 9, Iss 1, Pp 1-6 (2022)
Abstract The present CEUS Cardiac Exam Protocols represent the first effort to promulgate a standard set of protocols for optimal administration of ultrasound enhancing agents (UEAs) in echocardiography, based on more than two decades of experience i
Externí odkaz:
https://doaj.org/article/f445b5d1089640dea2f072e07fa233ea
Publikováno v:
Echo Research and Practice, Vol 7, Iss 3, Pp 19-28 (2020)
Background: Resting myocardial perfusion (MP) and wall motion (WM) imaging during real-time myocardial contrast echocardiography (MCE) improves the detection of coronary artery disease (CAD). However, its prognostic role in different clinical setting
Externí odkaz:
https://doaj.org/article/f18ea9c0569d4e24a02f45be84c9f043
Autor:
Thomas R. Porter, Sasha K. Shillcutt, Mark S. Adams, Georges Desjardins, Kathryn E. Glas, Joan J. Olson, Richard W. Troughton
Publikováno v:
Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, Vol 4, Iss 1, Pp 122-136 (2020)
Externí odkaz:
https://doaj.org/article/4fd06dd90dc24a73844e17e524443e71
Autor:
Pedro Enrique Alcaraz, Skylar J. Davidson, Evan Shreeve, Rainee Meuschke, Marek Romanowski, Russell S. Witte, Thomas R. Porter, Terry O. Matsunaga
Publikováno v:
Ultrasound in Medicine & Biology. 49:1058-1069
Publikováno v:
American Heart Journal. 254:66-76
Aortic valve stenosis (AS) has traditionally been approached in hemodynamic terms. Although hemodynamics and symptoms have formed the basis of recommending interventional treatment in AS, other factors reflecting left ventricular and valvular and/or
Autor:
Nicholas Kipshidze MD, PhD, DSc, Patrick Iversen PhD, Thomas R. Porter MD, Nodar Kipshidze MPH, Fakiha Siddiqui BDS, George Dangas MD, PhD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Definitive pharmacological therapies for COVID-19 have yet to be identified. Several hundred trials are ongoing globally in the hope of a solution. However, nearly all treatments rely on systemic delivery but COVID-19 damages the lungs preferentially
Externí odkaz:
https://doaj.org/article/ad011341f43a485d9037d71461842d25
Autor:
Shelby Kutty, MD, PhD, MHCM, Na Liu, MD, PhD, Jia Zhou, MD, PhD, Yunbin Xiao, MD, PhD, Juefei Wu, MD, PhD, David A. Danford, MD, John Lof, MS, Feng Xie, MD, Thomas R. Porter, MD
Publikováno v:
JACC: Basic to Translational Science, Vol 2, Iss 6, Pp 748-756 (2017)
Inertial cavitation inducing ultrasound-mediated microbubble treatments can produce resolution of vasospasm and restoration of distal arterial flow after peripheral artery injury. Resolution of catheter-induced vasospasm is likely to be nitric oxide-
Externí odkaz:
https://doaj.org/article/e7ed40b8f8b84ef1a0f8a3ec8ffd6e1e
Autor:
Thomas R. Porter
Publikováno v:
JACC: Cardiovascular Imaging. 16:236-238
Publikováno v:
JACC: Cardiovascular Imaging. 15:345-360
Contrast ultrasound has a variety of applications in cardiovascular medicine, both in diagnosing cardiovascular disease as well as providing prognostic information. Visualization of intravascular contrast microbubbles is based on acoustic cavitation,